← All companies
BCRX
BioCryst Pharmaceuticals, Inc.
$8.81
-0.43 -4.65%
Key statistics
from XBRL data in SEC filingsMarket cap
$2.24B
Revenue (TTM)
$886M
Net income (TTM)
-$458M
EPS (TTM)
$-1.77
P/E ratio
—
Dividend yield
—
Free cash flow
$345M
Cash
$172M
Total assets
$465M
Gross margin
—
52-week range
$6.00 – $11.22
Recent SEC filings
40 most recentAnnual, quarterly & current reports
8-K
Exit or disposal costs; Regulation FD disclosure
Jun 29, 2026
8-K
Director or officer change; Shareholder vote results
Jun 12, 2026
10-Q
Quarter ended 2026-03-31
May 6, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
May 6, 2026
8-K
Regulation FD disclosure
May 4, 2026
10-K
Fiscal year ended 2025-12-31
Feb 26, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure
Feb 26, 2026
8-K/A
Director or officer change
Jan 23, 2026
8-K
Entered a material agreement; Completed an acquisition or disposition; Took on a direct financial obligation; Regulation FD disclosure
Jan 23, 2026
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Jan 12, 2026
8-K
Regulation FD disclosure
Jan 9, 2026
8-K
Other events
Dec 12, 2025
8-K
Director or officer change
Dec 11, 2025
8-K
Other events
Dec 3, 2025
10-Q
Quarter ended 2025-09-30
Nov 4, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Nov 3, 2025
8-K
Entered a material agreement; Results of operations (earnings release); Director or officer change; Other events
Oct 14, 2025
8-K
Entered a material agreement; Other events
Oct 1, 2025
8-K
Director or officer change
Aug 11, 2025
10-Q
Quarter ended 2025-06-30
Aug 5, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Aug 4, 2025
8-K
Director or officer change; Regulation FD disclosure
Jul 31, 2025
8-K
Director or officer change; Regulation FD disclosure
Jul 7, 2025
8-K
Entered a material agreement
Jun 30, 2025
8-K
Other events
Jun 27, 2025
8-K
Other events
Jun 25, 2025
8-K
Director or officer change; Shareholder vote results
Jun 16, 2025
8-K
Director or officer change
Jun 4, 2025
8-K
Other events
May 14, 2025
10-Q
Quarter ended 2025-03-31
May 6, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
May 5, 2025
8-K
Director or officer change
May 1, 2025
8-K
Director or officer change
Apr 10, 2025
8-K
Other events
Mar 11, 2025
8-K
Director or officer change
Mar 4, 2025
10-K
Fiscal year ended 2024-12-31
Feb 25, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure; Other events
Feb 24, 2025
8-K
Regulation FD disclosure
Jan 13, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Jan 10, 2025
8-K
Regulation FD disclosure
Jan 8, 2025